Pfizer (PFE) Inks $5.3B COVID Pill Supply Deal With U.S.


Zacks Equity Research

via Nasdaq - Nov 19, 2021


Pfizer announced that it has signed a contract agreement with the U.S. government for the supply of 10 million treatment courses of its investigational oral COVID-19 drug, Paxlovid, subject to regulatory authorization from the FDA. The company has already submitted an application to the FDA seeking Emergency Use Authorization (“EUA”) for the oral candidate for the treatment of mild-to-moderate COVID-19 in patients at increased risk of hospitalizations or death.


Pfizer has also initiated rolling submission seeking authorization/approval for Paxlovid in several other countries and planning to submit regulatory applications in countries across the globe.


Per the agreement with the U.S. government, Pfizer will deliver the contracted 10 million treatment courses of Paxlovid in the next few weeks of this year, following a potential EUA, as well as in 2022. In exchange, the company will receive $5.29 billion from the U.S. government.


We note that Pfizer’s EUA application for Paxlovid is backed by clinical data from an interim analysis of a phase II/III study, EPIC-HR, that demonstrated that treatment with Paxlovid reduced the risk of hospitalization or death by 89% in non-hospitalized adult patients with COVID-19 at high risk of progressing to severe illness compared to placebo within three days of symptom onset.


Pfizer’s Paxlovid treatment course...


Pfizer Inc. Price ...


Zacks Rank ...


more, including links, charts



White House’s Dr. Choucair: Mandates key to beating COVID-19


Tanya Albert Henry, American Medical Association (AMA)

Nov 19, 2021


The first wave of COVID-19 vaccine mandates for employees came from leaders at health care organizations and private employers, ­and had the desired effect. The requirements moved the needle on getting more Americans immunized against a virus that has upended the lives of countless families and already killed more than 750,000 Americans.


“Take United Airlines, for example. Now there are over 99% of their employees vaccinated. Tyson Foods has over 96% of their employees vaccinated. They didn’t start there. They started in the mid-50s or high-50s, so we know vaccine requirements work,” Bechara Choucair, MD, said during a recent episode of “AMA COVID-19 Update.” He is the vaccinations coordinator on the White House COVID-19 Response Team.


What new federal requirements would do ...


Boost to the economy ...


Physician’s role is essential ...


more, including links